Tipp

Diagnosis of Adnexal Masses—Do we Really Need Computed Tomography?

Zeitschrift:: Journal für Gynäkologische Endokrinologie/Österreich > Ausgabe 2/2020

Autor:: Ruben Heremans

Wichtige Hinweise

Lecture manuscript on the occasion of the XXIX Scientific Meeting of the Working Group for Gynaecological Oncology (AGO) of the Austrian Society of Gynaecology and Obstetrics (OEGGG) 2020, 18th Austrian Congress “Cancer in Women”, April 22–25, 2020, Salzburg. The meeting was cancelled due to the Sars-CoV‑2 pandemic.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Without Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Jetzt einloggen Kostenlos registrieren

Timmerman D, Valentin L, Bourne TH, Collins WP, Verrelst H, Vergote I (2000) Terms definitions and measurements to describe the sonographic features of adnexal tumors a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 16:500–505 CrossRef

Timmerman D, Testa AC, Bourne T, Ferrazzi E, Ameye L, Konstantinovic ML et al (2005) Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol 23:8794–8801 CrossRef

Timmerman D, Ameye L, Fischerova D, Epstein E, Melis GB, Guerriero S et al (2010) Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. BMJ 341:c6839 CrossRef

Timmerman D, Van Calster B, Testa A, Savelli L, Fischerova D, Froyman W et al (2016) Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group. Am J Obstet Gynecol 214:424–437 CrossRef

Van Calster B, Van Hoorde K, Valentin L, Testa AC, Fischerova D, Van Holsbeke C et al (2014) Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ 349:g5920 CrossRef

Westwood M, Ramaekers B, Lang S, Grimm S, Deshpande S, de Kock S et al (2018) Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis. Health Technol Assess 22:1–264 CrossRef

Andreotti RF, Timmerman D, Strachowski LM, Froyman W, Benacerraf BR, Bennett GL et al (2020) O‑RADS US Risk Stratification and Management System: a consensus guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee. Radiology 294:168–185 CrossRef

Thomassin-Naggara I, Poncelet E, Jalaguier-Coudray A, Guerra A, Fournier LS, Stojanovic S et al (2020) Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses. JAMA Netw Open 3:e1919896 CrossRef

Fischerova D, Burgetova A (2014) Imaging techniques for the evaluation of ovarian cancer. Best Pract Res Clin Obstet Gynaecol 28:697–720 CrossRef

10.

Soussan M, Des Guetz G, Barrau V, Aflalo-Hazan V, Pop G, Mehanna Z et al (2012) Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy. Eur Radiol 22:1479–1487 CrossRef

11.

Michielsen K, Vergote I, Op de Beeck K, Amant F, Leunen K, Moerman P et al (2014) Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. Eur Radiol 24:889–901 CrossRef

12.

Gadelhak B, Tawfik AM, Saleh GA, Batouty NM, Sobh DM, Hamdy O et al (2019) Extended abdominopelvic MRI versus CT at the time of adnexal mass characterization for assessing radiologic peritoneal cancer index (PCI) prior to cytoreductive surgery. Abdom Radiol (NY) 44:2254–2261 CrossRef

Titel: Diagnosis of Adnexal Masses—Do we Really Need Computed Tomography?
Autor:: Ruben Heremans
Publikationsdatum: 01.06.2020
DOI: https://doi.org/10.1007/s41974-020-00134-y
Verlag: Springer Vienna
Zeitschrift: Journal für Gynäkologische Endokrinologie/Österreich Gynäkologie-Kontrazeption-Menopause-Reproduktionsmedizin
Ausgabe 2/2020
Print ISSN: 1997-6690
Elektronische ISSN: 1996-1553

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Diagnosis of Adnexal Masses—Do we Really Need Computed Tomography?

Publisher’s Note

Without Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Publisher’s Note

Without Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

Triple-negativer Brustkrebs – Wann Chemo nach der Op?

News-Screen Assistierte Reproduktion

Das Corpus luteum im gynäkologischen Ultraschall

Editorial

Störungen der Pubertätsentwicklung

Vorteile bioidentischer Sexualhormone in der systemischen menopausalen Hormontherapie